Skip to main content
. 2016 Dec;7(6):828–837. doi: 10.21037/jgo.2016.08.09

Table 5. Characteristics of patients by baseline vascular endothelial growth factor-A (VEGF-A) level (n=30).

Characteristic VEGF-Alo (<57.8 pg/mL) (No., %) VEGF-Ahi (>57.8 pg/mL) (No., %) P value
Lymph node status 0.43
   uN0 6 [40] 3 [20]
   uN+ 9 [60] 12 [80]
R0 resection* 0.65
   Yes 10 [71] 12 [86]
   No 4 [29] 2 [14]
pCR*,# 0.60
   Yes 3 [28] 1 [8]
   No 11 [72] 13 [92]

*, one patient each who was VEGF-Alo and VEGF-Ahi was taken off study for lack of response to induction chemotherapy and are therefore invaluable for surgical outcomes; #, 1 of the 5 patients who achieved a pathologic complete response did not have a baseline VEGF measurement. VEGF, vascular endothelial growth factor.